0001808805-24-000067.txt : 20240925 0001808805-24-000067.hdr.sgml : 20240925 20240925182921 ACCESSION NUMBER: 0001808805-24-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240923 FILED AS OF DATE: 20240925 DATE AS OF CHANGE: 20240925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Godwin Mary E. CENTRAL INDEX KEY: 0001439716 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 241325753 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 981541723 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wk-form4_1727303354.xml FORM 4 X0508 4 2024-09-23 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001439716 Godwin Mary E. C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVE. EAST SEATTLE WA 98102 0 1 0 0 Senior VP, Operations 0 Common Stock 2024-09-23 4 M 0 47031 0.46 A 47031 D Common Stock 2024-09-23 4 S 0 47031 2.865 D 0 D Stock Option (Right to Buy) 0.46 2024-09-23 4 M 0 47031 0 D 2030-01-30 Common Stock 47031 353337 D Represents the weighted average share price of an aggregate total of 47,031 shares purchased in the price range of $2.80 to $3.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 21, 2020. /s/ Matthew Murphy, as Attorney-in-Fact 2024-09-25